Walleye Capital LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$202,182
-22.2%
2,257
-45.1%
0.00%
-85.7%
Q1 2022$260,000
-33.7%
4,111
-44.3%
0.01%
-41.7%
Q4 2021$392,000
-46.7%
7,384
-29.1%
0.01%
-42.9%
Q3 2021$736,000
+94.2%
10,421
+139.6%
0.02%
-50.0%
Q3 2020$379,000
-34.2%
4,349
-34.0%
0.04%
-55.8%
Q1 2019$576,0006,5900.10%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders